Amarin reported $739M in Market Capitalization this January of 2023, considering the latest stock price and the number of outstanding shares.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Abbvie ABBV:US USD 237.3B 33.36B
Alnylam Pharmaceuticals ALNY:US USD 24.62B 6.97B
Amarin AMRN:US USD 440M 152M
AstraZeneca AZN:LN USD 154.08B 13.26B
Biocryst Pharmaceuticals BCRX:US USD 2.34B 376M
Dbv Technologies DBVT:US USD 329M 87M
Esperion Therapeutics ESPR:US USD 446M 45M
GlaxoSmithKline GSK:LN GBP 58.86B 5.75B
Halozyme Therapeutics HALO:US USD 5.45B 622M
Heron Therapeutics HRTX:US USD 501M 215M
Intercept Pharmaceuticals ICPT:US USD 574M 164M
IONIS PHARMACEUT IONS:US USD 6.28B 1.03B
JAZZ PHA JAZZ:US USD 8.36B 1.39B
Nektar Therapeutics NKTR:US USD 600M 108M
Neurocrine Biosciences NBIX:US USD 10.16B 841M
Novartis NOVN:VX USD 181.55B 12.79B
Teva Pharmaceutical Industries TEVA:US USD 8.65B 168M